Ultra Hybrid® FVRCP has been shown to be effective for vaccination against feline rhinotracheitis, calicivirus (novel), calicivirus (traditional) and panleukopenia viruses.
Ultra Hybrid® vaccines use 50% less volume than standard vaccines. This minimal injection volume delivers a more comfortable experience for the cat.
For cats 8 weeks and older. A combination vaccine of modified live viruses plus two strains of killed calicivirus.
Cautions: Keep out of reach of children and animals. A small percentage of cats may experience transient lethargy, pyrexia and anorexia and some cats may experience stinging itching or pain at the injection site. In rare cases, hypersensitivity or anaphylaxis may occur requiring appropriate treatment.
Do not vaccinate pregnant queens.
Do not mix with other products except as specified. In case of human expose, contact a physician. Use entire contents when first opened.
Storage: Store in the dark at 35°F to 46°F. Avoid freezing. Shake well.
Shake well. Inject one 0.5 mL dose subcutaneously. Repeat in 3 to 4 weeks. In cases where the animal is less than 16 weeks old, the final dose should be given no earlier than 16 weeks of age. The need for an annual booster vaccination has not been established for this product. Consultation with a veterinarian is recommended.
For healthy cats 8 weeks of age or older.
Feline rhinotracheitis, panleukopenia, - Modified live
Feline calicivirus (novel), calicivirus (traditional), - Killed virus
Thimerosal, neomycin and polymyxin B added as preservatives.